You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
|
|---|---|
| Published in |
Journal of Clinical Oncology, January 2024
|
| DOI | 10.1200/jco.23.00458 |
| Pubmed ID | |
| Authors |
Lucas Moreno, Rebekah Weston, Cormac Owens, Dominique Valteau-Couanet, Marion Gambart, Victoria Castel, C. Michel Zwaan, Karsten Nysom, Nicolas Gerber, Aurora Castellano, Genevieve Laureys, Ruth Ladenstein, Jochen Rössler, Guy Makin, Dermot Murphy, Bruce Morland, Sucheta Vaidya, Estelle Thebaud, Natasha van Eijkelenburg, Deborah A. Tweddle, Giuseppe Barone, Julie Tandonnet, Nadege Corradini, Pascal Chastagner, Catherine Paillard, Francisco J. Bautista, Soledad Gallego Melcon, Bram De Wilde, Lynley Marshall, Juliet Gray, Susan A. Burchill, Gudrun Schleiermacher, Louis Chesler, Andrew Peet, Martin O. Leach, Kieran McHugh, Roisin Hayes, Neil Jerome, Hubert Caron, Jennifer Laidler, Nicola Fenwick, Grace Holt, Veronica Moroz, Pamela Kearns, Simon Gates, Andrew D.J. Pearson, Keith Wheatley, Dominique Valteau-Couanet, Francisco José Bautista, Dermot Murphy, Guy Makin, Estelle Thebaut, Natasha van Eijkelenburg, Dave Hobin, Sucheta Vaidya, Martin Elliott, Gudrun Schleiermacher, Cormac Owens, Giuseppe Barone, Deborah Tweddle, Victoria Castel, Karsten Nysom, Julie Tandonnet, Nadege Corradini, Pascal Chastagner, Marion Gambart, Sarah Jannier, Aurora Castellano, Soledad Gallego, Carole Coze, Anne Auvrignon, Anne Sophie Defachelles, Ricardo Lopez Almaraz, Nicolas Gerber, Ruth Ladenstein, Bram De Wilde, Benedicte Brichard, Roberto Luksch, Michel Zwaan, Beck Popovic Maja, Courtney Willis, Juliet Gray, Simone Hettmer, Lothar Schweigerer, Udo Kontny, Holger Christiansen, Alberto Garaventa, Anthony Ng, Lisa Howell, Daniel Yeomanson |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 29% |
| United Kingdom | 4 | 29% |
| Romania | 1 | 7% |
| Armenia | 1 | 7% |
| Finland | 1 | 7% |
| Unknown | 3 | 21% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 71% |
| Scientists | 2 | 14% |
| Practitioners (doctors, other healthcare professionals) | 2 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 2 | 20% |
| Student > Master | 1 | 10% |
| Student > Doctoral Student | 1 | 10% |
| Professor | 1 | 10% |
| Unspecified | 1 | 10% |
| Other | 2 | 20% |
| Unknown | 2 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 30% |
| Engineering | 2 | 20% |
| Biochemistry, Genetics and Molecular Biology | 1 | 10% |
| Chemistry | 1 | 10% |
| Unspecified | 1 | 10% |
| Other | 0 | 0% |
| Unknown | 2 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1285. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2024.
All research outputs
#10,232
of 25,381,864 outputs
Outputs from Journal of Clinical Oncology
#6
of 22,045 outputs
Outputs of similar age
#186
of 298,465 outputs
Outputs of similar age from Journal of Clinical Oncology
#2
of 197 outputs
Altmetric has tracked 25,381,864 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,045 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.